123 related articles for article (PubMed ID: 8684425)
1. Synergy of fluconazole with macrophages for antifungal activity against Candida albicans.
Garcha UK; Brummer E; Stevens DA
Mycopathologia; 1995-1996; 132(3):123-8. PubMed ID: 8684425
[TBL] [Abstract][Full Text] [Related]
2. Synergy of human neutrophils with fluconazole in killing Candida species.
Brummer E; Stevens DA
Mycopathologia; 1996; 134(3):115-20. PubMed ID: 8981777
[TBL] [Abstract][Full Text] [Related]
3. Interactions of a prenylated flavonoid from Dalea elegans with fluconazole against azole- resistant Candida albicans.
Barceló S; Peralta M; Calise M; Finck S; Ortega G; Diez RA; Cabrera JL; Pérez C
Phytomedicine; 2017 Aug; 32():24-29. PubMed ID: 28732804
[TBL] [Abstract][Full Text] [Related]
4. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species.
Garcha UK; Brummer E; Stevens DA
J Infect Dis; 1995 Dec; 172(6):1620-3. PubMed ID: 7594731
[TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
6. Antifungal action of Hevea brasiliensis latex. Its effect in combination with fluconazole on Candida albicans growth.
Giordani R; Gachon C; Buc J; Regli P; Jacob JL
Mycoses; 1999; 42(7-8):465-74. PubMed ID: 10546488
[TBL] [Abstract][Full Text] [Related]
7. Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.
Valentin A; Le Guennec R; Rodriguez E; Reynes J; Mallie M; Bastide JM
Antimicrob Agents Chemother; 1996 Jun; 40(6):1342-5. PubMed ID: 8725998
[TBL] [Abstract][Full Text] [Related]
8. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
9. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Purimetla N; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Apr; 42(4):907-10. PubMed ID: 9559806
[TBL] [Abstract][Full Text] [Related]
10. Quercetin sensitizes fluconazole-resistant candida albicans to induce apoptotic cell death by modulating quorum sensing.
Singh BN; Upreti DK; Singh BR; Pandey G; Verma S; Roy S; Naqvi AH; Rawat AK
Antimicrob Agents Chemother; 2015 Apr; 59(4):2153-68. PubMed ID: 25645848
[TBL] [Abstract][Full Text] [Related]
11. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
[TBL] [Abstract][Full Text] [Related]
12. Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.
Brummer E; Nassar F; Stevens DA
Antimicrob Agents Chemother; 1994 Sep; 38(9):2158-61. PubMed ID: 7811035
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
[TBL] [Abstract][Full Text] [Related]
14. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.
Kurita N; Brummer E; Oarada M; Miyaji M
Med Mycol; 2003 Apr; 41(2):131-6. PubMed ID: 12964845
[TBL] [Abstract][Full Text] [Related]
16. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
Zhanel GG; Saunders DG; Hoban DJ; Karlowsky JA
Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
[TBL] [Abstract][Full Text] [Related]
17. Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans.
Gujral S; Brummer E; Stevens DA
J Infect Dis; 1996 Oct; 174(4):888-90. PubMed ID: 8843238
[TBL] [Abstract][Full Text] [Related]
18. Quantitative screening for fluconazole-amphotericin B antagonism in several Candida albicans strains by a comparative agar diffusion assay.
Scheven M; Scheven C
Mycoses; 1996; 39(3-4):111-4. PubMed ID: 8767003
[TBL] [Abstract][Full Text] [Related]
19. Analysis of fluconazole effect on Candida albicans viability during extended incubations.
Sohnle PG; Hahn BL; Fassel TA; Kushnaryov VM
Med Mycol; 1998 Feb; 36(1):29-36. PubMed ID: 9776809
[TBL] [Abstract][Full Text] [Related]
20. Effect of fluconazole on viability of Candida albicans over extended periods of time.
Sohnle PG; Hahn BL; Erdmann MD
Antimicrob Agents Chemother; 1996 Nov; 40(11):2622-5. PubMed ID: 8913476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
